Date: Wednesday, November 6, 2024
Time: 2:00pm – 3:00pm ET (Updated Starting Time)

Topic:

Explore KOVALTRY® With Confidence

Overview:

Clinical Trial Results, Dosing and Pharmacokinetics of KOVALTRY® in adults, adolescents and children

Speaker:

Maissaa Janbain, M.D., MSCR

Associate Director, Louisiana Center for Bleeding and Clotting Disorders

Associate Professor of Medicine, Tulane University New Orleans, LA

Maissaa Janbain, MD., MSCR is Currently an Associate Professor of Clinical Medicine at Tulane University; and serves as the Director of the Louisiana Center for bleeding and clotting disorders. Dr. Janbain has received multiple awards and grants (including National Hemophilia Foundation Fellowship Award 2014, Louisiana Clinical and Translational Research Roadmap Scholarship 2015, HTRS Mentored Research Award 2017 and School of Medicine Scientist Pipeline Program 2017) that allow her to focus her research and time on taking care of patients with benign hematologic disorders, with an emphasis on bleeding disorders such as hemophilia and von Willebrand disease but also thrombosis and platelet disorders. She has presented at several national and international meetings and her research work has been published in several journals. Dr. Janbain is a founding member of the VENUS (venous thromboembolic network of the US) network and a member of the steering committee of ADVANCE US, co- chairing the project sub-committee.